Research on Cannabis Compounds and Metabolic Dysfunction in Adults
This article explores cannabis compounds metabolic dysfunction and their potential impact on reversing disease affecting one-third of adults. The research highlights emerging findings on cannabis compounds as a possible intervention for metabolic health.…
Cannabis compounds could reverse disease affecting one-third of adults – New York Post
Recent studies highlight non-psychoactive cannabis compounds metabolic disease potential, especially for conditions like metabolic syndrome. These compounds offer therapeutic promise without psychoactive effects. However, clinical validation is needed…
Drugs Inhibiting Cannabinoid Receptor Type-1 Reduce Obesity-Associated Steatohepatitis
Cannabinoid receptor type 1 antagonist obesity treatments inhibit progression of steatohepatitis by modulating immune disturbances. This receptor plays a key role in liver inflammation and fat accumulation. Blocking CB1 receptors shows promise in…